SOPHiA GENETICS (SOPH) Free Cash Flow (2020 - 2026)

SOPHiA GENETICS has disclosed Free Cash Flow across 7 years of filings, most recently posting -$7.5 million for Q2 2026.

• In Q2 2026, Free Cash Flow rose 20.16% year-over-year to -$7.5 million; the TTM figure through Jun 2026 stood at -$38.2 million (down 1.8% YoY), while the FY2025 annual figure was -$35.1 million, up 19.7% from the prior year.
• Free Cash Flow came in at -$7.5 million for Q2 2026 at SOPHiA GENETICS, up from -$14.2 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$7.5 million in Q2 2026 to a low of -$22.2 million in Q3 2022.
• Average Free Cash Flow over 5 years is -$12.1 million, with a median of -$10.4 million recorded in 2024.
• Year-over-year, Free Cash Flow slumped 67.01% in 2022 and soared 45.85% in 2023.
• Over 5 years, Free Cash Flow stood at -$9.0 million in 2022, then sank by 37.3% to -$12.4 million in 2023, then increased by 15.77% to -$10.5 million in 2024, then increased by 25.45% to -$7.8 million in 2025, then climbed by 3.54% to -$7.5 million in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were -$7.5 million in Q2 2026, -$14.2 million in Q1 2026, and -$7.8 million in Q4 2025.